Search

everythinglearnresearchcommunity

for

Search:↓

A man with syphilitic alopecia and neurosyphilis was successfully treated with penicillin, leading to symptom improvement and resolution of hair loss.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Imatinib can cause hair loss due to lichen planopilaris.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Finasteride, a hair loss drug, caused a skin rash that went away when the drug was stopped and returned when used again.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

The document concludes that treatment improved skin lesions but not scalp hair loss in two patients with Graham-Little-Piccardi-Lassueur syndrome.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Demodex mites can cause skin issues, especially in people with weak immune systems.

Zinc supplements can resolve skin issues caused by zinc deficiency.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Most hospitalized children with skin issues were boys, with allergic skin diseases like atopic dermatitis being most common, and treatments were usually topical.

Most pregnant women in Northeast India experience normal skin changes, with specific pregnancy-related skin conditions being rare.

Children's skin diseases and treatments differ from adults and require specific approaches.

Pregnancy can cause skin changes and may affect pre-existing skin conditions, with some treatments not safe for use during pregnancy.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Fresh plasma transfusions did not help treat Leiner disease in an infant.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

HIV patients with lower CD4 T cell counts often have more skin problems.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

A 46-year-old man showed symptoms of a rare condition usually seen in postmenopausal women, highlighting the need for dentist-dermatologist collaboration.

A man had a unique case of three skin conditions happening together.

Mogamulizumab can cause hair loss and skin rashes.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.